cagrilintide semaglutide combination phase 3 2024 Cagrilintide–semaglutide (CagriSema) as an add-on to basal insulin in adults with type 2 diabetes (REIMAGINE 3): a randomised, double-blind, placebo-controlled, multicentre, study Novo Nordisk to explore CagriSema

Tip: Only order from licensed Canadian pharmacies that verify prescriptions

Patients should not consume alcohol excessively, as it may cause severe low blood sugar

Soluble fiber sources like apples, pears, oats, and beans are particularly effective at stimulating GLP-1 secretion, which complements the medication's effect

The silicone coating that helps the needle slide in smoothly wears off, causing more friction and potential damage to your skin

In 0.25mg, 0.5mg, 1mg, 1.7mg and 2.4mg pens there are 4 doses , which means each pen will last for 4 weeks of treatment, as long as youre taking 1 injection a week

May 2026: 13 more lawsuits have been added to the federal NAION MDL against Novo Nordisk (Rybelsus) and other GLP-1 companies, bringing the total to 86